A first major description of the prognostic relevance of stromal PDGFRβ expression was published on invasive breast cancer through conventional IHC analysis of a population-based cohort of more than 200 cases and uncovered significant associations between high stromal expression and shorter recurrence-free and breast cancer–specific survival based on univariate analyses [95]. The gene discussed is PDGFRB; the disease is breast cancer.